Works matching IS 11771062 AND DT 2025 AND VI 29 AND IP 1


Results: 13
    1
    2
    3

    Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance: Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on ESCAT: A. Lebedeva et al

    Published in:
    Molecular Diagnosis & Therapy, 2025, v. 29, n. 1, p. 91, doi. 10.1007/s40291-024-00748-4
    By:
    • Lebedeva, Alexandra;
    • Belova, Ekaterina;
    • Kavun, Alexandra;
    • Taraskina, Anastasiia;
    • Bartoletti, Michele;
    • Bièche, Ivan;
    • Curigliano, Giuseppe;
    • Dupain, Célia;
    • Rios-Hoyo, Alejandro;
    • Kamal, Maud;
    • Luchini, Claudio;
    • Poyarkov, Stanislav;
    • Le Tourneau, Christophe;
    • Veselovsky, Egor;
    • Mileyko, Vladislav;
    • Ivanov, Maxim
    Publication type:
    Article
    4
    7
    8
    9
    10
    11
    12
    13

    Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort: Targeted Therapy in Salivary Gland Cancer: M. Linxweiler et al.

    Published in:
    Molecular Diagnosis & Therapy, 2025, v. 29, n. 1, p. 103, doi. 10.1007/s40291-024-00750-w
    By:
    • Linxweiler, Maximilian;
    • Wemmert, Silke;
    • Braun, Felix Leon;
    • Körner, Sandrina;
    • Brust, Lukas Alexander;
    • Knebel, Moritz;
    • Klamminger, Gilbert Georg;
    • Wagner, Mathias;
    • Morris, Luc G. T.;
    • Kühn, Jan Philipp
    Publication type:
    Article